ACR 2022 Tweet by Adela Castro
Tweet
Related Content
Podcast
DERM on RheumNow PODCAST (September 2026)
RheumNow
Sep 30, 2026
The Derm on RheumNow podcast is a review of recent citations and content curated for dermatologists – addressing Psoriasis, PsA, CLE, calcinosis, CTD skin disorders. dermatology drugs, biologics, and JAK inhibitors.
Features Dr. Jack Cush, Editor at RheumNow.com.
Show Notes:
FDA Grants Priority…
Reuters and the Wall Street Journal report that both Novartis and Bristol Myers Squibb (BMS) have paused their autoimmune disease CAR-T cell trials due to safety concerns, including deaths.Novartis has halted their cellular therapy trials with rap-cel (multiple autoimmune indications) because of 3…
Podcast
DERM on RheumNow PODCAST (October 2026)
RheumNow
Oct 31, 2026
Every day, every month, rheumatology publishes news and reports on JAK inhibitors, IL-17s, IL-23s, lupus, myositis, and scleroderma – all which could change how you practice dermatology. I'm Jack Cush from RheumNow, and This is Derm on RheumNow.
This month’s podcast will Scratch the surface and…


